DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Holmøy T, Beiske AG, Zarnovicky S, Myro AZ, Røsjø E, Kerty E.
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
BMC Neurol 2016;
16 (01) 197
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.